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246a Monday, February 22, 2010such as Crouzon syndrome and bladder cancer. This mutation has been shown
to stabilize the isolated TM domain dimers in lipid membranes, but it is not
known if it stabilizes the full length FGFR3 receptor dimers in the plasma mem-
brane of mammalian cells.
To address the effect of the mutation in mammalian cells, we have determined
free energies of dimerization for the wild type and mutant FGFR3 in mamma-
lian (HEK293T and CHO) plasma membranes using the QI Fo¨rster resonance
energy transfer (FRET) technique [Li et al.,2008]. The measured change in the
dimerization free energy due to the Ala391Glu mutation is 1.2 kcal/mol, con-
sistent with previous reports of hydrogen bond strength in proteins, as well as
results for the isolated FGFR3 TM domains. Thus, we have shown that the mu-
tation stabilizes the full length FGFR3 dimers in mammalian cells. We propose
that this dimer stabilization is the major cause for FGFR3 overactivation and
human pathologies.
Li E,Placone J,Merzlyakov M, Hristova K (2008) Quantitative measurements
of protein interactions in a crowded cellular environment.Anal Chem
80:5976-5985.
1281-Pos
The Physical Basis Behind Achondroplasia, the Most Common Form of
Human Dwarfism
Lijuan He, Kalina Hristova.
Johns Hopkins University, Baltimore, MD, USA.
Fibroblast growth factor receptor 3 (FGFR3) is a receptor tyrosine kinase which
plays an important role in long bone development. The Gly380Arg mutation in
FGFR3 transmembrane domain has been linked to achondroplasia, the most
common form of human dwarfism. However, the exact mechanism underlying
the pathology is under debate. One hypothesis is that the mutation stabilizes the
active FGFR3 dimer in the plasma membrane. To test this hypothesis, here we
measure the activation of wild type and mutant FGFR3 in mammalian cells,
and analyze the activation using a physical-chemical model accounting for di-
merization, ligand binding and phosphorylation probabilities. Our results dem-
onstrate that the achondroplasia mutation does not increase the dimerization
propensity of FGFR3. Instead, the data suggest that the mutation induces
a structural change in the unliganded dimer. We propose that this structural
change is a cause for pathogenesis in achondroplasia.
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Spectroscopic Design of Phospholamban Mutants to Treat Heart Failure
Simon J. Gruber1, Suzanne Haydon1, Kim N. Ha1, Roger J. Hajjar2,
Gianluigi Veglia1, David D. Thomas1.
1University of Minnesota, Minneapolis, MN, USA, 2Mt. Sinai Medical
School, New York, NY, USA.
Ca2þ cycling through the SR in muscle cells is largely controlled by the Ca-
pump (SERCA). SERCA transports Ca2þ into the SR and is inhibited by phos-
pholamban (PLB) at submicromolar [Ca2þ], and this inhibition can be relieved
by adrenergic stimulation. Contraction takes place when the Ca-release channel
opens and the intracellular [Ca2þ] is high. One of the most common symptoms
of heart failure (HF) is impaired calcium handling, frequently resulting from
decreased SERCA activity. We are using EPR and NMR to study the relation-
ships among structure, dynamics, and function of PLB, with the goal of design-
ing LOF-PLB mutants (PLBM) that can compete with WT-PLB and thus relieve
SERCA inhibition. Several studies have shown that a pseudophosphorylated
PLB (S16E-PLB) is effective for gene therapy in rodents and sheep, and we
are using spectroscopic methods to refine this approach. We have developed
a system for examining the function and interactions of SERCA and PLB in
HEK cells. Active SERCA is expressed at a level high above basal ATPase ac-
tivity, and cells are co-transfected with WT-PLB and/or PLBM to measure
SERCA inhibition in living cells. Unlike S16E-PLB, these mutants are able
to respond to adrenergic stimulation. In addition to quantifying SERCA activity
in the presence of PLBM, we measure the ability of each mutant to compete
with WT-PLB for binding to SERCA. This is done by measuring fluorescence
resonance energy transfer (FRET) between labeled SERCA and WT-PLB. If
PLBM displaces WT-PLB, less energy is transferred between fluorophores
and a decrease in FRET is observed. Based on these results, rAAV is used to
test PLBM in rodent and porcine models of HF for efficacy in vivo and ability
to respond to adrenergic stimulation, with the goal of developing a novel, gene
therapy based treatment for HF.
1283-Pos
The Activity of a Low-Affinity L-Arginine Transporter Quenches Peroxy-
nitrite-Induced Fluorescence in Ventricular Cardiomyocytes
Jayalakshmi Ramachandran, R. Daniel Peluffo.
UMDNJ-New Jersey Medical School, Newark, NJ, USA.
We discovered a low-affinity, high-capacity L-arginine (L-Arg) transport pro-
cess in rat cardiomyocytes consistent with the activity of the CAT-2A memberof the y(þ) family of cationic amino acid transporters (Peluffo, J Physiol,
580:925-936, 2007), set to function in parallel with the previously described
high-affinity, low-capacity CAT-1 (Lu et al., Biosci Rep, 29:271-281, 2009).
In assessing the role of a low-affinity transporter in this setting, we propose
that CAT-2A protects cardiac muscle cells by ensuring the availability of
proper L-Arg levels for the synthesis of nitric oxide (NO) via NO synthase
(NOS). To test this hypothesis, acutely-isolated cardiomyocytes were loaded
with the dye coelenterazine that greatly increases its fluorescence quantum
yield in the presence of peroxynitrite (ONOO ) and superoxide radicals. Cells
were then exposed to 20 or 100 mM ONOO and changes in fluorescence were
followed with a spectrofluorometer. Addition of extracellular L-Arg reduced
ONOO-induced fluorescence in a concentration-dependent manner, an effect
that was not mimicked by D-arginine or L-lysine and was fully blocked by
the NOS inhibitor L-NAME. L-Arg reduced fluorescence with Ki values of
0.84 5 0.12 and 1.26 5 0.16 mM at 20 and 100 mM ONOO , respectively.
L-Arg ‘‘zero effect’’ on ONOO-induced fluorescence was also dependent on
ONOO concentration, with values of 145 and 363 mM for 20 and 100 mM
ONOO , respectively. Below these values, decreasing concentrations of L-
Arg progressively increased ONOO-induced fluorescence, an effect that was
also blocked by L-NAME. All these effects can be explained by NOS-mediated
NO synthesis, which may turn to ONOO production at limiting L-Arg. Since
ONOO has detrimental effects on cardiac contractility, these results suggest
a cardioprotective role for the low-affinity L-Arg transporter, ensuring proper
supply of NOS substrate under a variety of physiological and pathological con-
ditions.
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Studies on the Structure and Function of the Intracellular Region of the
Plexin-B1 Transmembrane Receptor
Prasanta K. Hota1, Yufeng Tong2, Junia Y. Penachioni3, Luca Tamagnone3,
Hee-Won Park2, Matthias Buck1.
1School of Medicine, Physiology and Biophysics, Case Western Reserve
University, Cleveland, OH, USA, 2Structural Genomics Consortium,
Department of Pharmacology, University of Toronto, Toronto, ON, Canada,
3Institute for Cancer Research and Treatment, University of Torino,
Candiolo, Italy.
Plexin family are unique transmembrane receptors protein known to regulate
several cellular processes including axonal guidance in the developing nervous
system. Upon activation, plexin initiates signaling processes, which involve
several small GTPases of the Ras and Rho families (R-Ras, Rac1, Rnd1, and
RhoD) that regulates cytoskeletal dynamics and cell adhesion. Plexins are
unique amongst transmembrane receptors because its several cytoplasmic re-
gions interact directly with small GTPases. Specifically, plexins possess a do-
main with homology to GTPase activating proteins (GAPs). As part of their ac-
tivation, plexin family shows GAP activity toward R-Ras. However, the
mechanism of activation is not known till date because of lack of information
about the structure and function of these receptor proteins. In this context, we
have studied the structure, function of intracellular region of PlexinB1 and their
binding interaction with small GTPase. The structure is monomeric and binds
to Rac1, Rnd1 as well as Rras, but not H-Ras. These findings suggest that the
monomeric form of the intracellular region is primed for GAP activity and ex-
tend a model for plexin activation.
[1] Tong, Y., et al. (2008) Structure 16, 246-258.[2] Bouguet-Bonnet, S. &
Buck, M (2008) J.Mol.Biol. 377,1474-87.[3] Tong, Y, et al. (2007) J.Biol.
Chem. 282, 37215-37224.[4] Hota, P. & Buck, M. (2009) Protein Science,
18(5):1060-71.[5] Tong, Y., et al. (2009) J. Biol. Chem. Submitted.
Protein Structure I
1285-Pos
Structural and Functional Studies of Bacterial Toxin-Antitoxin Systems
Gregory Verdon1, Lauren DeStefano2, Chi Wang3, Gregory Boel3,
Guy Montelione4, Nancy Woychik5, John F. Hunt3.
1Weill Medical College of Cornell University, New York, NY, USA,
2UMDNJ-RWJMS Department of Molecular Genetics and Microbiology &
Immunology, Piscataway, NJ, USA, 3Columbia University, Dept. of
Biological Sciences, New York, NY, USA, 4Rutgers - State University of
New Jersey, New Brunswick, NY, USA, 5UMDNJ-RWJMS Department of
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TA systems have recently been linked to medically important processes such
as biofilm formation, bacterial persistence after exposure to antibiotics, and
bacterial pathogenesis. Toxin-Antitoxin (TA) systems are stable protein com-
plexes consisting of a toxin, whose action is mechanistically distinct from exo-
toxins (e.g. botulinum, anthrax or cholera toxins), in complex with an anti-
toxin, its specific inhibitor. The release of TA toxin occurs under specific
Monday, February 22, 2010 247aconditions (e.g. stress). TA toxins have a bacteriostatic effect that can lead to
cell death if sustained. Although the mechanisms of action for a few TA toxins
have been uncovered, the intracellular targets of many others have not been
identified. Our latest structural and functional data on such complexes will
be presented.
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Overproduction, Purification and Structure Determination of Human
Dual Specificity Phosphatase 14
George Lountos, Joseph Tropea, Scott Cherry, David Waugh.
National Cancer Institute-Frederick, Frederick, MD, USA.
Dual-specificity phosphatases (DUSPs) are enzymes that participate in the reg-
ulation of biological processes such as cell growth, differentiation, transcription
and metabolism. A number of DUSPs are able to dephosphorylate phosphory-
lated serine, threonine and tyrosine residues on mitogen-activated protein ki-
nases (MAPKs) and thus are also classified as MAPK phosphatases (MKPs).
As an increasing number of DUSPs are being identified and characterized, there
is a growing need to understand their biological activities at the molecular
level. There is also significant interest in identifying DUSPs that could be po-
tential targets for drugs that modulate MAPK-dependent signaling and immune
responses, which have been implicated in a variety of maladies including can-
cer, infectious diseases and inflammatory disorders. Here, the overproduction,
purification and crystal structure at 1.88 Angstroms resolution of human dual-
specificity phosphatase 14, DUSP14 (MKP6), are reported. DUSP14 has been
reported in the literature to play potentially important roles in T cell regulation
and may also be involved in gastric cancer. The determination of the three-di-
mensional structure of DUSP14 should aide the study of DUSP14 at the molec-
ular level and may also accelerate the discovery and development of novel ther-
apeutic agents.
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Structural Studies on Mutants of HMG CoA Reductase from Pseuodomo-
nas Mevalonii
Moumita Sen, Nicklaus C. Steussy, Chandra Duncan, Victor W. Rodwell,
Cynthia V. Stauffacher.
Purdue University, West Lafayette, IN, USA.
HMG-CoA reductase catalyzes the four-electron reduction of HMG-CoA to
free CoA and mevalonate. This is one of the few double oxidation/reduction
reactions in intermediary metabolism that take place in a single active site.
In addition to the unusual enzymology, this reaction is of interest because it
is the committed step of the fundamental mevalonate isoprenoid pathway. In
animals this pathway produces cholesterol, the steroid hormones and a variety
of signaling molecules based on the isoprenoid building block (1). In bacteria
the pathway is equally important, and has been shown to be essential to the vir-
ulence of Staphylococcal and Streptococcal bacteria (2). To better understand
the nature of this reaction, our laboratory has undertaken a comprehensive
structural study of the mechanism of HMG-CoA reductase in bacteria utilizing
the enzyme from Pseudomonas mevalonii.
HMG-CoA reductase is an obligate dimer, with each monomer consisting of
a large domain, a small domain, and a flap domain (2, 3) that is disordered
in the apoenzyme structure. The flap domain is ordered in the crystal structure
only in the presence of ligand and co-factors, where it closes over the active
site, positioned by a network of hydrogen bonds that include the ligand and
co-factor. Two residues proposed to be important in flap domain movement
have been mutated. Mutant proteins have been crystallized, soaked with vari-
ous combinations of ligands and co-factors, and their structures have been
solved at 1.95-2.40A˚. These structures, reinforced with kinetic analysis of
the mutants, demonstrate the essentiality of this closure in the reaction and re-
veal how these residues are involved in flap domain movement.
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Structure of the E. Coli Gyrase DNA Binding and Cleavage Core Reveals
A Unique Domain
Allyn Schoeffler, James Berger.
University of California, Berkeley, Berkeley, CA, USA.
DNA topoisomerases are essential enzymes that sustain chromosome super-
coiling homeostasis in all forms of life. DNA gyrase, a heterotetrameric
type IIA topoisomerase, has the unique ability to introduce negative super-
coils into DNA, helping maintain bacterial genomes in a compact, under-
wound state. Though all gyrase orthologs use a set of homologous domains
and a central ‘‘two-gate’’ mechanism for passing one DNA segment through
another, they also exhibit critical family-specific differences. For example,
the metal- and DNA-binding TOPRIM domain of gyrases found in many
gamma- and beta-proteobacteria contains a 170-amino acid insertion of un-known function. We have solved the crystal structure of the E.coli gyrase
DNA binding and cleavage core, visualizing this insertion for the first
time. Biochemical analyses of a structure-guided deletion mutant lacking
this region reveal that it may help coordinate the activities of gyrase’s distal
ATPase and DNA binding gates.
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Structure of Crohn’S Disease-Related Proteins and their Binding to Class
II MHC
Lihui Liu, Guo Yi, Hongmin Li.
Wadsworth Center, Albany, NY, USA.
T cell response to enteric bacteria is important in inflammatory bowel disease.
pfiT is a T-cell superantigen associated with human Crohn’s disease. The bac-
terial superantigens are a class of protein toxins that share the capacity to in-
duce massive activation of the human immune system. These molecules si-
multaneously bind to major histocompatibility complex class II molecules
on the surface of antigen-presenting cells and T-cell receptors (TCRs) on T
cells to stimulate large numbers of T cells. The aim of this study is to analyze
the molecular mechanism of superantigen recognition by host receptors. Here,
we report the crystal structure of pfiT. This protein was overexpressed in Es-
cherichia coli and purified though GST-affinity and size exclusion chromatog-
raphy. The protein is selenomethionine labeled and single wavelength anom-
alous dispersion method was used for determination of the crystal structure.
The superantigen crystallizes in the monoclinic space group P21, with two
molecules in asymmetric unit cell. The structure was determined to 2.5A˚ res-
olution. In addition, we performed radiolabeled competitive binding assays
between three superantigens: pfiT, Mycoplasma arthritidis-derived mitogen
(MAM), PA2885, a novel open reading frame (ORF) in the Pseudomonas aer-
uginosa genome. Analyses showed that both the microbial homologuepfit and
PA2885, just as potent superantigen MAM, are capable of binding to target
mammalian cells. Moreover, we labeled these superantigens with FITC and
analyzed them by FACS in PBMC. The statistic results show that antibody
against HLA-DR has strong effect to block these SAg’ binding ability with
PBMC, and antibodies against HLA-DQ and DP can also compete binding
site in a much weaker manner. These findings support the concept that
pfiT, PA2885, MAM are superantigens and can bind to class II MHC mole-
cule .
Research is funded by the Crohn’ & Colitis Foundation of America.
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Structural and Metal-Binding Characterization of the C-terminal
Metallochaperone Domain of the Membrane Fusion Protein SilB from
Cupriavidus Metallidurans CH34
Beate Bersch1, Kheiro-Mouna Derfoufi2, Fabien De Angelis2,
Elisabeth Ngonlong Ekende´2, Max Mergeay3, Jean-Marie Ruysschaert2,
Guy Vandenbussche2.
1Institut de Biologie Structurale, Grenoble, France, 2Universite´ Libre de
Bruxelles, Brussels, Belgium, 3Belgian Nuclear Research Centre, Mol,
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The b-proteobacterium Cupriavidus metallidurans CH34 has an outstanding
ability to grow on harsh environments such as heavy-metal contaminated sites.
The regulated transport of heavy metal ions out of the cell via tripartite efflux
systems is one of the mechanisms used by the bacteria for detoxification. These
protein complexes span the entire bacterial cell envelope, and are composed of
an inner membrane transporter belonging to the resistance nodulation cell divi-
sion (RND) family, an outer membrane protein member of the Outer Mem-
brane Factor (OMF) family, and a periplasmic adaptor protein, member of
the Membrane Fusion Protein (MFP) family. SilABC is one of the 12 putative
efflux systems detected in C. metallidurans CH34 genome and is most probably
involved in silver and copper trafficking. We report here on the characterization
of the C-terminal domain of the periplasmic adaptor protein SilB. This C-ter-
minal extension exists only in SilB homologs and is not present in other
MFPs. A potential Ag(I)/Cu(I) coordination site was detected on the basis of
the amino acid sequence and the metal-binding specificity was confirmed by
mass spectrometry. NMR solution structure of the apo-form showed that
SilB C-terminal domain adopts a b-barrel structure. Comparison of chemical
shift data between the apo-and metallated-form demonstrated the implication
of two methionine, one histidine and one tryptophan residues in the metal co-
ordination site. Fluorescence quenching and UV-visible data are consistent
with a cation-tryptophan p-interaction. With respect to its three-dimensional
structure and metal-binding specificity, the SilB C-terminal domain closely re-
sembles CusF, a small periplasmic protein belonging to the CusCFBA efflux
system involved in silver and copper resistance in E. coli. Our study suggests
